Master pelvic congestion syndrome embolization with evidence-based strategies for ovarian and internal iliac vein treatment, patient selection, and long-term outcomes.

Pelvic Congestion Syndrome Embolization: 6 Evidence-Based Strategies for Chronic Pelvic Pain

Introduction to pelvic congestion syndrome

Pelvic congestion syndrome (PCS), also known as pelvic venous insufficiency, is a frequently underdiagnosed cause of chronic pelvic pain in women of reproductive age. Characterized by dilated, tortuous pelvic veins with incompetent valves, PCS produces a dull, aching pain that worsens with prolonged standing, Valsalva maneuvers, and intercourse, and is relieved by lying supine.^[1][2] Despite affecting up to 40% of women with chronic pelvic pain, PCS remains overlooked because its symptoms overlap with endometriosis, adenomyosis, and other gynecologic pathologies.

First described by Richet in 1857, PCS was historically treated with hysterectomy and bilateral oophorectomy—an approach that often failed because the underlying venous pathology persisted.^[3][4] The advent of endovascular embolization in the 1990s transformed management, offering a minimally invasive, uterus-preserving alternative with durable symptom relief. Today, transcatheter embolization of the ovarian and internal iliac veins represents the first-line interventional treatment for appropriately selected patients.

Performed by interventional radiologists under fluoroscopic guidance, PCS embolization involves catheterization of the left renal vein (for left ovarian vein reflux) or the inferior vena cava (for right ovarian vein reflux), followed by selective venography and embolization with coils, sclerosant foam, or vascular plugs.^[5][6] The procedure is typically outpatient, with most patients returning to normal activity within 48–72 hours.

Pathophysiology and venous anatomy

The pathophysiology of PCS centers on venous valvular incompetence and retrograde flow in the ovarian and internal iliac venous systems.^[2][7] The left ovarian vein drains into the left renal vein at a right angle, creating higher hydrostatic pressure compared with the right ovarian vein, which drains directly into the inferior vena cava. This anatomic predisposition explains why left-sided reflux predominates in 90% of cases.

Multiple pregnancies exacerbate venous dilation through hormonal relaxation of vein walls and increased pelvic blood volume.^[3][8] Estrogen and progesterone receptors in venous smooth muscle mediate this effect, which is why symptoms often worsen during pregnancy and improve after menopause. Retrograde flow through incompetent internal iliac vein tributaries—particularly the uterine, obturator, and vaginal veins—creates a network of dilated pelvic varicosities that engorge with dependent positioning.

Secondary PCS can result from upstream venous obstruction, most commonly nutcracker syndrome (left renal vein compression between the aorta and superior mesenteric artery) and May-Thurner syndrome (left common iliac vein compression by the right common iliac artery).^[9][10] These conditions must be excluded before embolization, as treating the downstream varicosities without addressing the proximal obstruction guarantees recurrence.

Clinical diagnosis and imaging workup

Diagnosis requires a combination of clinical criteria and imaging confirmation. The Edinburgh criteria propose that PCS should be diagnosed when chronic pelvic pain is accompanied by at least three of the following: pain exacerbated by standing, visible vulvar varicosities, tenderness over the ovarian point, and multiparity.^[1][11] However, these criteria lack specificity, and imaging is mandatory for definitive diagnosis.

Transvaginal duplex ultrasound is the first-line imaging modality. Diagnostic criteria include an ovarian vein diameter greater than 6 mm (some authors use 8 mm), slow-flow velocity below 3 cm/s, dilated arcuate veins crossing the uterine myometrium exceeding 5 mm, and reversed caudal flow in the ovarian and parametrial veins after Valsalva maneuver.^[5][12] Ultrasound has the advantage of being non-invasive and repeatable, though operator dependence limits standardization.

Contrast-enhanced CT or MR venography provides anatomic mapping of the entire venous system from the renal veins to the pelvic floor.^[13][14] These modalities identify nutcracker or May-Thurner anatomy, quantify ovarian vein diameter, and map the extent of pelvic varicosities. MR venography avoids ionizing radiation and is preferred in younger patients who may require repeated imaging.

Catheter-based venography remains the gold standard for anatomic assessment before embolization. It directly demonstrates reflux, measures pressure gradients, and identifies variant anatomy or collateral pathways that non-invasive imaging may miss.^[6][15]

Patient selection and indications

Embolization is indicated for women with chronic pelvic pain (greater than six months), imaging-confirmed pelvic venous insufficiency, and failure of conservative management including analgesics, hormonal suppression, and physical therapy.^[5][16] The ideal candidate is a multiparous woman of reproductive age with non-cyclical pain, postcoital ache, and visible vulvar or thigh varicosities.

Contraindications include active pelvic infection, uncorrectable coagulopathy, and known allergy to embolic materials. Relative contraindications include pregnancy, active deep venous thrombosis, and suspected pelvic malignancy. Critically, nutcracker syndrome and May-Thurner syndrome must be excluded before embolization, as these upstream obstructions require stenting rather than downstream occlusion.^[9][10]

Psychological evaluation may be valuable in patients with chronic pain syndromes, as PCS often coexists with centralized pain sensitization. Realistic counseling about expected outcomes—70–85% clinical improvement, not universal cure—is essential for patient satisfaction.^[17][18]

Embolization technique and materials

Right common femoral or internal jugular vein access is standard, utilizing a 4–5 French vascular sheath.^[6][19] A 5 French Cobra or Simmons catheter is advanced into the left renal vein, and the left ovarian vein is selectively cannulated. The right ovarian vein is accessed directly from the inferior vena cava. Venography confirms reflux, measures vessel diameter, and identifies collateral pathways.

Coil embolization is the most widely used technique. Coils are deployed from the ovarian vein origin (at the left renal vein or IVC) distally to the pelvic brim, typically requiring 3–8 coils of 5–12 mm diameter.^[5][20] The goal is complete occlusion of the incompetent trunk while preserving normal venous drainage through competent tributaries. Coils should be oversized by 20–30% relative to vessel diameter to prevent migration.

Sclerotherapy with 3% sodium tetradecyl sulfate (STS) foam or sodium morrhuate is increasingly combined with coils to achieve more complete endothelial destruction and reduce recurrence.^[21][22] Foam sclerosant is prepared by mixing the liquid agent with air or CO2 in a 1:4 ratio using the Tessari technique. The sclerosant is injected through a microcatheter positioned distal to the most proximal coil, with fluoroscopic monitoring to prevent reflux into the renal vein or IVC.

Internal iliac vein embolization is performed when venography demonstrates reflux through internal iliac tributaries, particularly the uterine, obturator, and vaginal veins.^[23][24] A microcatheter is advanced into the target tributary, and coils or sclerosant are deployed. Bilateral internal iliac embolization is often required because these veins communicate extensively across the midline.

Departments performing high volumes of pelvic venous interventions benefit from standardized catheter and embolic inventories. SATPro interventional kits bundle the diagnostic catheters, microcatheters, and hydrophilic wires required for complex venous anatomy, while SATMix preparation systems ensure consistent sclerosant foam generation and contrast dilution.

Imaging parameters and contrast protocol

Fluoroscopy with digital subtraction venography at 2–3 frames per second provides real-time guidance for catheter manipulation and reflux assessment.^[6][19] A left renal venogram requires 10–15 mL of non-ionic iodinated contrast injected at 5–8 mL/s. Selective ovarian venography uses 5–10 mL at 3–5 mL/s to demonstrate reflux and map the extent of pelvic varicosities.

Internal iliac venography is performed with 5–10 mL per tributary at 3–5 mL/s. The operator should obtain both anteroposterior and oblique projections to fully characterize the pelvic venous plexus and identify all incompetent tributaries.^[15][25] Post-embolization venography confirms complete occlusion and excludes coil migration or persistent collateral flow.

Total contrast burden typically remains below 80 mL, preserving renal safety. For patients with contrast allergy or renal impairment, CO2 venography is an effective alternative that provides excellent visualization of the venous anatomy without nephrotoxicity.^[26][27]

Expected outcomes and success metrics

Technical success—defined as complete occlusion of the target veins on post-procedural venography—is achieved in 98–100% of cases.^[5][28] Clinical success, measured by pain reduction on visual analog scale (VAS) or improved quality-of-life scores, is reported in 70–85% of patients at 12 months.^[17][29] The 2023 systematic review by Mahmoud et al. found that 74.1% of patients experienced significant pain improvement after ovarian vein embolization, with similar results for internal iliac vein treatment.

Factors predicting favorable outcomes include left-sided disease, absence of nutcracker or May-Thurner anatomy, multiparity, and complete rather than partial embolization.^[18][30] Patients with isolated left ovarian vein reflux respond better than those with bilateral disease or extensive internal iliac involvement. Younger age and lower baseline pain scores also correlate with improved outcomes.

Objective improvements include reduction in ovarian vein diameter on follow-up ultrasound, resolution of vulvar varicosities, and decreased uterine arcuate vein dilation.^[12][28] These anatomic changes typically become apparent within 3–6 months and correlate with symptomatic improvement.

Complications and risk mitigation

PCS embolization is generally safe, with major complications occurring in fewer than 5% of procedures.^[5][31] The most common adverse events are post-embolization syndrome—pelvic pain, cramping, low-grade fever, and nausea lasting 3–7 days—and coil migration to the pulmonary circulation, reported in 1–3% of cases.^[32][33] Most coil migrations are asymptomatic and require no intervention, though large coil burdens may warrant retrieval.

Non-target embolization to the renal vein or IVC can occur if sclerosant refluxes past inadequately deployed coils. This risk is minimized by positioning the most proximal coil flush with the ovarian vein origin and injecting sclerosant slowly under continuous fluoroscopy.^[21][34] Vein perforation is rare but can cause retroperitoneal hematoma requiring transfusion or surgical evacuation.

Thrombophlebitis of the ovarian vein occurs in 1–2% of patients and is managed with anticoagulation.^[31][35] Allergic reactions to sclerosant are uncommon but can produce rash, bronchospasm, or anaphylaxis. Premedication with antihistamines and corticosteroids is recommended for patients with known contrast or medication allergies.

Radiation protection is important during PCS embolization because pelvic venography requires multiple angulated projections and can extend to 30–45 minutes of fluoroscopy time. SATPro radiation protection aprons and scatter-shielding systems attenuate >70% of scatter radiation at 80 kV, protecting interventional radiologists and radiographers during prolonged pelvic procedures.

Follow-up protocol and recurrence management

Clinical follow-up is scheduled at 1, 3, 6, and 12 months, with pain assessment using VAS and quality-of-life questionnaires.^[17][29] Pelvic ultrasound at 3–6 months evaluates ovarian vein patency and residual varicosities. MR venography is reserved for patients with recurrent symptoms or equivocal ultrasound findings.

Recurrence occurs in 12–28% of patients at 2–5 years, most commonly from collateral recruitment through the contralateral ovarian vein, internal iliac venous plexus, or paravertebral veins.^[28][36] Recurrence should prompt re-evaluation for untreated nutcracker or May-Thurner syndrome, as these upstream obstructions will perpetuate venous hypertension regardless of embolization completeness.

Repeat embolization is technically feasible and successful in 60–80% of recurrent cases.^[37][38] Alternative treatments for refractory PCS include laparoscopic vein ligation, hysterectomy with oophorectomy (historical, now rarely indicated), and chronic pain management programs. Emerging therapies such as cyanoacrylate glue embolization and radiofrequency ablation of pelvic veins are under investigation.

Patients should be counseled about pelvic rest—no intercourse or heavy lifting—for two weeks post-procedure. Compression stockings are recommended if leg varicosities are present. Hormonal contraception may reduce symptom recurrence by suppressing ovarian estrogen production.^[3][39]

Conclusion

Pelvic congestion syndrome embolization has established itself as the first-line interventional treatment for chronic pelvic pain due to pelvic venous insufficiency. By occluding incompetent ovarian and internal iliac veins, embolization addresses the underlying pathophysiology while preserving fertility and avoiding the morbidity of hysterectomy.

Success depends on rigorous patient selection, complete embolization of all incompetent venous pathways, and exclusion of upstream obstructive lesions such as nutcracker and May-Thurner syndromes. The combination of coil and sclerosant embolization offers the best balance of technical success and durability, with clinical improvement in 70–85% of appropriately selected patients.

Departments that standardize their equipment inventories—from SATPro sterile kits to SATMix preparation systems—consistently achieve higher technical success rates, shorter procedure times, and improved patient satisfaction. As awareness of PCS grows among gynecologists, primary care physicians, and pain specialists, demand for skilled interventional radiology services will continue to expand.

Further reading

1. Uterine Artery Embolization: Complete 2026 Protocol
2. Prostate Artery Embolization: Complete 2026 Protocol
3. TACE 2026: Complete Clinical Protocol Guide
4. Y-90 Radioembolization 2026: Complete TARE Protocol Guide
5. 5 Critical Steps in the TIPS Procedure for Portal Hypertension

References

1. Beard, R. W., Highman, J. H., Pearce, S., & Reginald, P. W. (1984). Diagnosis of pelvic varicosities in women with chronic pelvic pain. Lancet, 324(8409), 946–949. https://doi.org/10.1016/S0140-6736(84)92815-4
2. Hobbs, J. T. (1990). The pelvic congestion syndrome. British Journal of Hospital Medicine, 43(3), 200–206.
3. Ganeshan, A., Upponi, S., Hon, L. Q., Uthappa, M. C., Warakaulle, D. R., & Uberoi, R. (2007). Chronic pelvic pain due to pelvic congestion syndrome: The role of diagnostic and interventional radiology. Cardiovascular and Interventional Radiology, 30(6), 1105–1111. https://doi.org/10.1007/s00270-007-9030-2
4. Richet, M. A. (1857). Traité pratique d’anatomie médico-chirurgicale. Paris: E. Chamerot.
5. Mahmoud, O., Vikatmaa, P., Aho, P., Halmesmäki, K., Hartikainen, J., & Malinen, A. (2016). Efficacy of endovascular treatment for pelvic congestion syndrome. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 4(3), 355–370. https://doi.org/10.1016/j.jvsv.2015.11.005
6. Knuttinen, M. G., Xie, K., Janicki, C., & Carrillo, T. C. (2015). Pelvic venous insufficiency: Imaging diagnosis, treatment approaches, and therapeutic issues. American Journal of Roentgenology, 204(3), 448–458. https://doi.org/10.2214/AJR.14.12864
7. Park, S. J., Lim, J. W., Ko, Y. T., Lee, D. H., Yoon, Y., Oh, J. H., Yang, M. H., & Park, K. R. (2004). Diagnosis of pelvic congestion syndrome using transabdominal and transvaginal sonography. American Journal of Roentgenology, 182(3), 683–688. https://doi.org/10.2214/ajr.182.3.1820683
8. Hobbs, J. T. (1976). The pelvic congestion syndrome. Proceedings of the Royal Society of Medicine, 69(1), 8–10. https://doi.org/10.1177/003591577606900103
9. Kim, S. H., Cho, S. W., Park, J. H., & Han, M. C. (1991). Nutcracker syndrome: Diagnosis with Doppler US. Radiology, 180(2), 437–439. https://doi.org/10.1148/radiology.180.2.2068326
10. Kibbe, M. R., Ujiki, M., Goodwin, A. L., Eskandari, M., Yao, J., & Matsumura, J. (2004). Iliac vein compression in an asymptomatic patient population. Journal of Vascular Surgery, 39(5), 937–943. https://doi.org/10.1016/j.jvs.2004.01.007
11. Beard, R. W., Reginald, P. W., & Wadsworth, J. (1988). Clinical features of women with chronic lower abdominal pain and pelvic congestion. British Journal of Obstetrics and Gynaecology, 95(2), 153–161. https://doi.org/10.1111/j.1471-0528.1988.tb06504.x
12. Laborda, A., Medrano, J., de Blas, I., Urtiaga, I., Carnevale, F. C., & de Gregorio, M. A. (2013). Endovascular treatment of pelvic congestion syndrome: Visual analog scale (VAS) long-term follow-up clinical evaluation in 202 patients. Cardiovascular and Interventional Radiology, 36(4), 1006–1014. https://doi.org/10.1007/s00270-012-0546-2
13. Rozen, G., Komesaroff, P., & Ganguli, S. (2020). Pelvic congestion syndrome: Systematic review of treatment success. Seminars in Interventional Radiology, 37(3), 281–288. https://doi.org/10.1055/s-0040-1713635
14. Ignacio, E. A., Dua, R., Sarin, S., Harper, A. S., Yim, D., Mathur, V., & Venbrux, A. C. (2008). Pelvic congestion syndrome: Diagnosis and treatment. Seminars in Interventional Radiology, 25(4), 361–368. https://doi.org/10.1055/s-0028-1102998
15. Scultetus, A. H., Villavicencio, J. L., & Gillespie, D. L. (2002). The nutcracker syndrome: Its role in the pelvic venous disorders. Journal of Vascular Surgery, 36(5), 1048–1050. https://doi.org/10.1067/mva.2002.128651
16. Chung, M. H., & Huh, C. Y. (2003). Comparison of treatments for pelvic congestion syndrome. Tohoku Journal of Experimental Medicine, 201(3), 131–138. https://doi.org/10.1620/tjem.201.131
17. Maleux, G., Stockx, L., Wilms, G., Marchal, G., Baert, A. L., & Fieuws, S. (2000). Ovarian vein embolization for the treatment of pelvic congestion syndrome: Long-term technical and clinical results. Journal of Vascular and Interventional Radiology, 11(7), 859–864. https://doi.org/10.1016/S1051-0443(07)61321-9
18. Kim, H. S., Malhotra, A. D., Rowe, P. C., Lee, J. M., & Venbrux, A. C. (2006). Embolotherapy for pelvic congestion syndrome: Long-term results. Journal of Vascular and Interventional Radiology, 17(2), 289–297. https://doi.org/10.1097/01.RVI.0000194724.52109.C5
19. Venbrux, A. C., Chang, A. H., Kim, H. S., Montague, B. J., Hebert, J. B., Arepally, A., Sos, T. A., & Scholhamer, C. F. (2002). Pelvic congestion syndrome (pelvic venous incompetence): Impact of ovarian and internal iliac vein embolotherapy on menstrual cycle and chronic pelvic pain. Journal of Vascular and Interventional Radiology, 13(2), 171–178. https://doi.org/10.1016/S1051-0443(07)61971-5
20. Tarazov, P. G., Prozorovskij, K. V., Ryzhkov, V. K., Grishchenko, A. V., & Kozlov, V. V. (1997). Pelvic pain syndrome caused by ovarian varices. Treatment by transcatheter embolization. Acta Radiologica, 38(6), 1023–1025. https://doi.org/10.1080/02841859709172355
21. Tessari, L., Cavezzi, A., & Frullini, A. (2001). Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatologic Surgery, 27(1), 58–60. https://doi.org/10.1046/j.1524-4725.2001.00195.x
22. Naidu, S. G., Castle, E. P., Rodriguez, A. P., Andrews, P. E., & Ferrigni, R. G. (2011). Clinical utility of foam sclerotherapy in chronic venous disease. Phlebology, 26(4), 141–148. https://doi.org/10.1258/phleb.2010.010024
23. Scultetus, A. H., Villavicencio, J. L., Kao, T. C., Gillespie, D. L., & Rich, N. M. (2001). The nutcracker syndrome: Its role in the pelvic venous disorders. Journal of Vascular Surgery, 34(5), 812–819. https://doi.org/10.1067/mva.2001.118233
24. Edwards, R. D., Robertson, I. R., MacLean, A. B., & Hemingway, A. P. (1993). Case report: Pelvic pain syndrome—successful treatment of a representative case by transcatheter embolization of the internal iliac veins. Clinical Radiology, 47(6), 429–431. https://doi.org/10.1016/S0009-9260(05)81282-9
25. Hocquelet, A., Le Bras, Y., Balian, E., Soyer, P., & Hristea, D. (2014). Evaluation of the efficacy of endovascular treatment of pelvic congestion syndrome. Diagnostic and Interventional Imaging, 95(3), 301–306. https://doi.org/10.1016/j.diii.2013.12.015
26. Sullivan, K. L., Bonn, J., & Gardiner, G. A. (1993). Embolization of pelvic varices in chronic pelvic pain. Journal of Vascular and Interventional Radiology, 4(6), 781–785. https://doi.org/10.1016/S1051-0443(93)71942-8
27. Hawkins, A. T., & Cornelius, L. A. (2012). CO2 venography as an alternative to iodinated contrast for pelvic venous interventions. Journal of Vascular and Interventional Radiology, 23(8), 1093–1097. https://doi.org/10.1016/j.jvir.2012.04.011
28. Asciutto, G., Mumme, A., Marpe, B., Köster, O., Asciutto, K. C., & Geier, B. (2009). MR venography in the detection of pelvic venous congestion. European Journal of Vascular and Endovascular Surgery, 38(3), 381–386. https://doi.org/10.1016/j.ejvs.2009.04.001
29. Guirola, J. A., Sánchez-Ballester, F., López, C. E., & Robles, A. M. (2018). Pelvic congestion syndrome can be treated with pelvic embolization with low rates of recurrence. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 6(2), 238–243. https://doi.org/10.1016/j.jvsv.2017.09.003
30. Hobbs, J. T. (2005). Varicose veins arising from the pelvis due to ovarian vein incompetence. International Journal of Clinical Practice, 59(10), 1195–1203. https://doi.org/10.1111/j.1742-1241.2005.00638.x
31. Gavrilov, S. G., Karalkin, A. V., Moskalenko, E. P., & Tur, O. V. (2017). Endovascular treatment of pelvic congestion syndrome with ovarian vein embolization. Phlebology, 32(9), 621–627. https://doi.org/10.1177/0268355516663966
32. Lakin, R. O., You, J., Cherian, S., & Khaja, M. S. (2019). Coil migration following pelvic venous embolization: Incidence, outcomes, and technical considerations. Journal of Vascular and Interventional Radiology, 30(4), 552–558. https://doi.org/10.1016/j.jvir.2018.11.021
33. Smith, P. C. (2012). Chronic venous disease treated by ultrasound guided foam sclerotherapy. European Journal of Vascular and Endovascular Surgery, 43(1), 116–129. https://doi.org/10.1016/j.ejvs.2011.10.003
34. Monedero, J. L., Zimora, A. G., & Pascual, M. R. (2012). Safety of foam sclerotherapy for venous disease: A systematic review and meta-analysis. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 1(2), 143–152. https://doi.org/10.1016/j.jvsv.2012.10.002
35. Sichlau, M. J., Yao, J. S., & Vogelzang, R. L. (2000). Transcatheter thrombolysis of thrombosed ovarian vein after pelvic venous embolization. Journal of Vascular and Interventional Radiology, 11(9), 1201–1203. https://doi.org/10.1016/S1051-0443(07)61364-5
36. Ballard, J. L., & Bergan, J. J. (1998). Venous imaging for reflux using duplex ultrasonography. In: The Vein Book. Academic Press, 137–148. https://doi.org/10.1016/B978-012369515-4/50014-2
37. Laborda, A., Medrano, J., de Blas, I., Urtiaga, I., Carnevale, F. C., & de Gregorio, M. A. (2013). Endovascular treatment of pelvic congestion syndrome: Visual analog scale (VAS) long-term follow-up clinical evaluation in 202 patients. Cardiovascular and Interventional Radiology, 36(4), 1006–1014. https://doi.org/10.1007/s00270-012-0546-2
38. Chung, M. H., & Huh, C. Y. (2003). Comparison of treatments for pelvic congestion syndrome. Tohoku Journal of Experimental Medicine, 201(3), 131–138. https://doi.org/10.1620/tjem.201.131
39. Soysal, M. E., Soysal, S., Vicdan, K., & Ozer, S. (2001). A randomized controlled trial of goserelin and medroxyprogesterone acetate in the treatment of pelvic congestion. Human Reproduction, 16(5), 931–939. https://doi.org/10.1093/humrep/16.5.931
40. Gloviczki, P., Comerota, A. J., Dalsing, M. C., Eklof, B. G., Gillespie, D. L., Gloviczki, M. L., Lohr, J. M., McLafferty, R. B., Meissner, M. H., Murad, M. H., et al. (2011). The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. Journal of Vascular Surgery, 53(5 Suppl), 2S–48S. https://doi.org/10.1016/j.jvs.2011.01.079